FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Preferred Pharmaceuticals Alprazolam Tablets Recall

Alprazolam Tablets, USP 1mg, Generic for Xanax, Pkg Size: a) 30 tablets per bottle

Preferred Pharmaceuticals, Inc. · Anaheim, CA

Risk level
Class II
Reported by FDA
Mar 9, 2022
Recall ID
D-0642-2022
Check your lot numberHow we source this data

Summary

Preferred Pharmaceuticals recalled Alprazolam Tablets starting Feb 22, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0642-2022 on Mar 9, 2022. Reason: CGMP deviations. Status: Terminated.

Why it was recalled

CGMP deviations

Product description

Alprazolam Tablets, USP 1mg, Generic for Xanax, Pkg Size: a) 30 tablets per bottle, NDC: 68788-6381-03, b) 60 tablets per bottle, NDC: 68788-6381-06, c) 90 tablets per bottle, NDC: 68788-6381-09, Mfg: Par Pharmaceutical.

Lot numbers, UPCs & expiration codes

Lot #s: a) G2919M, I0619O, F1419J; b) H3019Q; c) F1219N, F1919D, H0219D, I0519R, J0319G, Exp. 03/31/2022.

Where it was sold

Nationwide in the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0642-2022
Classification
Class II
Status
Terminated
Recall initiated
Feb 22, 2022
FDA report date
Mar 9, 2022
Quantity
276 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Preferred Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-0642-2022, exactly as published.

Show all FDA fields
City
Anaheim
State
CA
Status
Terminated
Country
United States
Event ID
89656
Address
1250 N Lakeview Ave Ste O
Code information
Lot #s: a) G2919M, I0619O, F1419J; b) H3019Q; c) F1219N, F1919D, H0219D, I0519R, J0319G, Exp. 03/31/2022.
Postal code
92807-1801
Report date
Mar 9, 2022
Product type
Drugs
Recall number
D-0642-2022
Classification
Class II
Recalling firm
Preferred Pharmaceuticals, Inc.
Product quantity
276 bottles
Termination date
May 5, 2023
Reason for recall
CGMP deviations
Voluntary / mandated
Voluntary: Firm initiated
Product description
Alprazolam Tablets, USP 1mg, Generic for Xanax, Pkg Size: a) 30 tablets per bottle, NDC: 68788-6381-03, b) 60 tablets per bottle, NDC: 68788-6381-06, c) 90 tablets per bottle, NDC: 68788-6381-09, Mfg: Par Pharmaceutical.
Distribution pattern
Nationwide in the USA.
Recall initiation date
Feb 22, 2022
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Mar 1, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0642-2022, published Mar 9, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls